Shanghai Junshi Biosciences Co (HKSE:01877) PB Ratio : 1.73 (As of May. 14, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Shanghai Junshi Biosciences Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-14), Shanghai Junshi Biosciences Co's share price is HK$13.06. Shanghai Junshi Biosciences Co's Book Value per Share for the quarter that ended in Mar. 2024 was HK$7.57. Hence, Shanghai Junshi Biosciences Co's PB Ratio of today is 1.73.

The historical rank and industry rank for Shanghai Junshi Biosciences Co's PB Ratio or its related term are showing as below:

HKSE:01877' s PB Ratio Range Over the Past 10 Years
Min: 1.22 Med: 2.23 Max: 4.34
Current: 1.73

During the past 8 years, Shanghai Junshi Biosciences Co's highest PB Ratio was 4.34. The lowest was 1.22. And the median was 2.23.

HKSE:01877's PB Ratio is ranked better than
63.87% of 1312 companies
in the Biotechnology industry
Industry Median: 2.48 vs HKSE:01877: 1.73

During the past 3 years, the average Book Value Per Share Growth Rate was 0.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 16.90% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Shanghai Junshi Biosciences Co was 65.60% per year. The lowest was 0.10% per year. And the median was 36.50% per year.

Back to Basics: PB Ratio

Shanghai Junshi Biosciences Co PB Ratio Historical Data

The historical data trend for Shanghai Junshi Biosciences Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Junshi Biosciences Co PB Ratio Chart

Shanghai Junshi Biosciences Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

6.30

7.06

5.42

4.49

2.44

Shanghai Junshi Biosciences Co Quarterly Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
PB Ratio	Get a 7-Day Free Trial														-	2.41	-	2.44	1.30

Competitive Comparison of Shanghai Junshi Biosciences Co's PB Ratio

For the Biotechnology subindustry, Shanghai Junshi Biosciences Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Junshi Biosciences Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Junshi Biosciences Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Junshi Biosciences Co's PB Ratio falls into.

Shanghai Junshi Biosciences Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Shanghai Junshi Biosciences Co's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Mar. 2024)
	=	13.06	/	7.567
	=	1.73

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Shanghai Junshi Biosciences Co (HKSE:01877) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Shanghai Junshi Biosciences Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Junshi Biosciences Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Junshi Biosciences Co (HKSE:01877) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Junshi Biosciences Co Ltd (HKSE:01877) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

8SJ:Germany 688180:China

Address

Nos. 36 and 58, Hai Qu Road, Room 1003, Level 10, Building 2, Pilot Free Trade Zone, Shanghai, CHN

Website

https://www.junshipharma.com

Shanghai Junshi is a China-based biotechnology company that was founded in 2012 and listed on the Hong Kong Stock Exchange and STAR board of the Shanghai Stock Exchange in 2018 and 2020, respectively. It received approval for its first core asset at the end of 2018, a PD-1 inhibitor called Tuoyi, or toripalimab. It also successfully created etesevimab, one of the earliest neutralizing antibodies for COVID-19 treatment, which was out-licensed to Eli Lilly and obtained U.S. Food and Drug Administration approval in February 2021. It also has an adalimumab biosimilar approved in 2022 and is working on an oral COVID-19 treatment, VV116.

Shanghai Junshi Biosciences Co (HKSE:01877) Headlines

No Headlines